Western pharma lobbies to keep drug deal options with Chinese companies despite 2025 law
pstAsiatech · x · 2026-09-23
Western pharmaceutical companies are urging the US administration to let them keep doing deals with Chinese companies for promising drug candidates, despite a 2025 law restricting US investment in Chinese technology.
More from AGI Musings
- Google researcher's refugee childhood story pushback on the teen drop-out-to-SF founder narrative — satnam6502 · 2026-09-23
- Miles Brundage worries AI info flood is breaking our cognitive defenses — Miles_Brundage · 2026-09-23
- AI safety researcher David Krueger: CEO doom claims lack credibility, but transparency research is badly needed — DavidSKrueger · 2026-09-23
- AI Safety Researcher David Krueger on Extinction Risk, CEOs and Regulation — DavidSKrueger · 2026-09-23
- AI slop reveals what hiring and performance reviews should actually measure — LadyAshBorg · 2026-09-23
- AI use in math papers jumped from 1.39% to 14.09% in six months, arXiv study finds — rohanpaul_ai · 2026-09-23